V

Veracyte
D

VCYT

28.470
USD
-1.67
(-5.54%)
مغلق
حجم التداول
0
الربح لكل سهم
1
العائد الربحي
-
P/E
92
حجم السوق
2,219,087,659
أصول ذات صلة
A
ADPT
-0.53000
(-6.67%)
7.41500 USD
BMRN
BMRN
-0.810
(-1.19%)
67.490 USD
DXCM
DXCM
-6.280
(-9.22%)
61.810 USD
F
FATE
-0.07990
(-10.38%)
0.69010 USD
REGN
REGN
-14.36
(-2.30%)
610.88 USD
R
RGEN
-9.300
(-7.10%)
121.730 USD
T
TDOC
-0.27000
(-3.46%)
7.53000 USD
VEEV
VEEV
-4.852
(-2.14%)
221.550 USD
المزيد
الأخبار المقالات

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.